Carret Asset Management’s CVS Health CVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.33M Sell
18,568
-200
-1% -$15.4K 0.13% 128
2025
Q4
$1.49M Sell
18,768
-6,469
-26% -$510K 0.14% 119
2025
Q3
$1.9M Sell
25,237
-2,045
-7% -$140K 0.19% 99
2025
Q2
$1.88M Sell
27,282
-7,874
-22% -$516K 0.2% 100
2025
Q1
$2.38M Sell
35,156
-13,886
-28% -$831K 0.27% 84
2024
Q4
$2.2M Sell
49,042
-41,287
-46% -$2.32M 0.24% 88
2024
Q3
$5.68M Sell
90,329
-16,105
-15% -$940K 0.62% 48
2024
Q2
$6.29M Sell
106,434
-2,674
-2% -$167K 0.73% 35
2024
Q1
$8.7M Sell
109,108
-977
-0.9% -$74.6K 1.02% 22
2023
Q4
$8.69M Sell
110,085
-634
-0.6% -$45.1K 1.11% 16
2023
Q3
$7.73M Sell
110,719
-1,421
-1% -$101K 1.08% 17
2023
Q2
$7.75M Sell
112,140
-819
-0.7% -$58.3K 1.03% 16
2023
Q1
$8.39M Sell
112,959
-5,140
-4% -$431K 1.17% 17
2022
Q4
$11M Sell
118,099
-505
-0.4% -$48.7K 1.52% 10
2022
Q3
$11.3M Sell
118,604
-20
-0% -$1.98K 1.69% 11
2022
Q2
$11M Sell
118,624
-645
-0.5% -$63K 1.52% 11
2022
Q1
$12.1M Buy
119,269
+275
+0.2% +$28.9K 1.38% 12
2021
Q4
$12.3M Sell
118,994
-395
-0.3% -$36.5K 1.36% 13
2021
Q3
$10.1M Sell
119,389
-251
-0.2% -$21K 1.21% 16
2021
Q2
$9.98M Sell
119,640
-1,870
-2% -$153K 1.17% 18
2021
Q1
$9.14M Buy
121,510
+1,255
+1% +$91.4K 1.13% 19
2020
Q4
$8.21M Sell
120,255
-147
-0.1% -$9.56K 1.11% 17
2020
Q3
$7.03M Buy
120,402
+4,835
+4% +$301K 1.06% 19
2020
Q2
$7.51M Buy
115,567
+5,401
+5% +$340K 1.22% 18
2020
Q1
$6.54M Buy
110,166
+740
+0.7% +$49.4K 1.25% 15
2019
Q4
$8.13M Sell
109,426
-575
-0.5% -$40.4K 1.19% 17
2019
Q3
$6.94M Buy
110,001
+835
+0.8% +$49.5K 1.1% 21
2019
Q2
$5.95M Buy
109,166
+3,198
+3% +$172K 0.94% 26
2019
Q1
$5.71M Buy
105,968
+5,714
+6% +$353K 0.93% 25
2018
Q4
$6.57M Buy
100,254
+1,873
+2% +$140K 1.18% 17
2018
Q3
$7.75M Sell
98,381
-510
-0.5% -$36.5K 1.19% 17
2018
Q2
$6.36M Sell
98,891
-8
-0% -$527 1.04% 20
2018
Q1
$6.15M Buy
98,899
+3,580
+4% +$257K 1.01% 22
2017
Q4
$6.91M Buy
95,319
+191
+0.2% +$13.9K 1.08% 21
2017
Q3
$7.74M Sell
95,128
-455
-0.5% -$36K 1.25% 18
2017
Q2
$7.69M Buy
95,583
+8,650
+10% +$683K 1.29% 18
2017
Q1
$6.82M Buy
86,933
+1,005
+1% +$80.2K 1.22% 20
2016
Q4
$6.78M Sell
85,928
-3,213
-4% -$260K 1.28% 20
2016
Q3
$7.93M Buy
89,141
+2,175
+3% +$205K 1.48% 16
2016
Q2
$8.33M Sell
86,966
-10
-0% -$997 1.61% 13
2016
Q1
$9.02M Sell
86,976
-610
-0.7% -$59.3K 1.92% 10
2015
Q4
$8.56M Sell
87,586
-3,578
-4% -$350K 1.83% 11
2015
Q3
$8.8M Sell
91,164
-2,815
-3% -$296K 1.92% 7
2015
Q2
$9.86M Sell
93,979
-5,423
-5% -$554K 1.96% 6
2015
Q1
$10.3M Sell
99,402
-5,594
-5% -$566K 1.99% 6
2014
Q4
$10.1M Sell
104,996
-2,280
-2% -$201K 1.91% 8
2014
Q3
$8.54M Sell
107,276
-1,284
-1% -$101K 1.66% 15
2014
Q2
$8.18M Buy
108,560
+420
+0.4% +$31.7K 1.57% 15
2014
Q1
$8.1M Buy
108,140
+371
+0.3% +$26.2K 1.62% 13
2013
Q4
$7.71M Buy
107,769
+519
+0.5% +$33.3K 1.58% 13
2013
Q3
$6.09M Sell
107,250
-449
-0.4% -$26.8K 1.35% 16
2013
Q2
$6.16M Buy
+107,699
New +$6.24M 1.28% 18

Other funds holding CVS

Carret Asset Management's CVS Position: Q1 2026 in Review

Carret Asset Management reduced its CVS Health (CVS) stake by 1.1% in Q1 2026, selling an estimated $15.4K and leaving 18,568 shares worth $1.33M. The position accounts for 0.13% of the portfolio, ranked #128.

Carret Asset Management first reported a position in CVS in Q2 2013 and has held it in 52 quarters since. The position peaked at $12.3M in Q4 2021. 1,865 funds tracked by Wall St. Rank hold CVS as of Q1 2026.

  • Carret Asset Management held 18,568 shares of CVS Health worth $1.33M as of Q1 2026.
  • Carret Asset Management sold 200 CVS Health shares in Q1 2026, an estimated $15.4K.
  • CVS Health made up 0.13% of Carret Asset Management's portfolio in Q1 2026, its #128 holding.
  • Carret Asset Management first reported a position in CVS Health in Q2 2013 and has held it in 52 quarters since.
  • Carret Asset Management's CVS Health position peaked at $12.3M in Q4 2021.
  • 1,865 funds tracked by Wall St. Rank held CVS Health as of Q1 2026.

Based on Carret Asset Management's 13F filing for Q1 2026, filed 15 May 2026.